Radiolabeled methotrexate as a diagnostic agent of inflammatory target sites: A proof-of-concept study

Methotrexate (MTX), as a pharmaceutical, is frequently used in tumor chemotherapy and is also a part of the established treatment of a number of autoimmune inflammatory disorders. Radiolabeled MTX has been studied as a tumor-diagnostic agent in a number of published studies. In the present study, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Papachristou, Maria, Kastis, George A., Stavrou, Petros Z., Xanthopoulos, Stavros, Furenlid, Lars R., Datseris, Ioannis E., Bouziotis, Penelope
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783489/
https://www.ncbi.nlm.nih.gov/pubmed/29207127
http://dx.doi.org/10.3892/mmr.2017.8166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783489/
https://www.ncbi.nlm.nih.gov/pubmed/29207127
http://dx.doi.org/10.3892/mmr.2017.8166

Ejemplares similares